Johnson & Johnson (JNJ) Free Cash Flow (2009 - 2026)
Johnson & Johnson recorded quarterly Free Cash Flow of $1.5 billion in Q1 2026, down 73.23% quarter-over-quarter from $5.5 billion in Q4 2025, and down 56.64% year-over-year from $3.4 billion in Q1 2025.
Johnson & Johnson's Free Cash Flow history runs 18 years deep, the most recent figure standing at $1.5 billion for Q1 2026.
- In Q1 2026, Free Cash Flow fell 56.64% year-over-year to $1.5 billion; the TTM figure through Mar 2026 stood at $17.8 billion (down 12.7% YoY), while the FY2025 annual figure was $19.7 billion, down 0.73% from the prior year.
- Free Cash Flow came in at $1.5 billion for Q1 2026 at Johnson & Johnson, down from $5.5 billion in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $8.0 billion in Q3 2025 to a low of $1.5 billion in Q1 2026.
- A 5-year average of $4.3 billion and a median of $3.4 billion in 2025 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow soared 259.75% in 2023 and plunged 56.64% in 2026, its largest moves.
- Johnson & Johnson's Free Cash Flow stood at $3.4 billion in 2022, then surged by 86.06% to $6.3 billion in 2023, then fell by 14.39% to $5.4 billion in 2024, then advanced by 1.88% to $5.5 billion in 2025, then slumped by 73.23% to $1.5 billion in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered $1.5 billion, $5.5 billion, and $8.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | 346.00 Mn |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 3.01 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 1.47 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 3.56 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 2.93 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 1.48 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 2.43 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 2.18 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 757.00 Mn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 1.47 Bn |
| Mar 29, 2026 | 1.47 Bn |
| Dec 28, 2025 | 5.47 Bn |
| Dec 28, 2025 | 5.47 Bn |
| Sep 28, 2025 | 8.01 Bn |
| Sep 28, 2025 | 8.01 Bn |
| Jun 29, 2025 | 2.84 Bn |
| Jun 29, 2025 | 2.84 Bn |
| Mar 30, 2025 | 3.38 Bn |
| Mar 30, 2025 | 3.38 Bn |
| Dec 29, 2024 | 5.37 Bn |
| Dec 29, 2024 | 5.37 Bn |
| Sep 29, 2024 | 6.96 Bn |
| Sep 29, 2024 | 6.96 Bn |
| Jun 30, 2024 | 4.66 Bn |
| Jun 30, 2024 | 4.66 Bn |
| Mar 31, 2024 | 2.85 Bn |
| Mar 31, 2024 | 2.85 Bn |
| Dec 31, 2023 | 6.27 Bn |
| Dec 31, 2023 | 6.27 Bn |
| Oct 1, 2023 | 6.52 Bn |
| Oct 1, 2023 | 6.52 Bn |
| Jul 2, 2023 | 3.06 Bn |
| Jul 2, 2023 | 3.06 Bn |
| Apr 2, 2023 | 2.39 Bn |
| Apr 2, 2023 | 2.39 Bn |
| Jan 1, 2023 | 1.74 Bn |
| Jan 1, 2023 | 1.74 Bn |
| Apr 3, 2022 | 3.37 Bn |
| Apr 3, 2022 | 3.37 Bn |
| Oct 3, 2021 | 7.54 Bn |
| Oct 3, 2021 | 7.54 Bn |
| Jul 4, 2021 | 4.50 Bn |
| Jul 4, 2021 | 4.50 Bn |
| Apr 4, 2021 | 3.40 Bn |
| Apr 4, 2021 | 3.40 Bn |
| Jan 3, 2021 | 7.02 Bn |
| Jan 3, 2021 | 7.02 Bn |
| Sep 27, 2020 | 7.65 Bn |
| Sep 27, 2020 | 7.65 Bn |
| Jun 28, 2020 | 2.79 Bn |
| Jun 28, 2020 | 2.79 Bn |
| Mar 29, 2020 | 2.73 Bn |
| Mar 29, 2020 | 2.73 Bn |
| Dec 29, 2019 | 5.14 Bn |
| Dec 29, 2019 | 5.14 Bn |
| Sep 29, 2019 | 6.78 Bn |
| Sep 29, 2019 | 6.78 Bn |
| Jun 30, 2019 | 5.11 Bn |
| Jun 30, 2019 | 5.11 Bn |
| Mar 31, 2019 | 2.89 Bn |
| Mar 31, 2019 | 2.89 Bn |
| Dec 30, 2018 | 4.93 Bn |
| Dec 30, 2018 | 4.93 Bn |
| Sep 30, 2018 | 5.45 Bn |
| Sep 30, 2018 | 5.45 Bn |
| Jul 1, 2018 | 5.20 Bn |
| Jul 1, 2018 | 5.20 Bn |
| Apr 1, 2018 | 2.95 Bn |
| Apr 1, 2018 | 2.95 Bn |
| Dec 31, 2017 | 4.87 Bn |
| Dec 31, 2017 | 4.87 Bn |
| Oct 1, 2017 | 5.48 Bn |
| Oct 1, 2017 | 5.48 Bn |
| Jul 2, 2017 | 5.08 Bn |
| Jul 2, 2017 | 5.08 Bn |
| Apr 2, 2017 | 2.35 Bn |
| Apr 2, 2017 | 2.35 Bn |
| Jan 1, 2017 | 3.15 Bn |
| Jan 1, 2017 | 3.15 Bn |
| Apr 3, 2016 | 1.55 Bn |
| Apr 3, 2016 | 1.55 Bn |
| Sep 27, 2015 | 5.35 Bn |
| Sep 27, 2015 | 5.35 Bn |
| Jun 28, 2015 | 4.71 Bn |
| Jun 28, 2015 | 4.71 Bn |
| Mar 29, 2015 | 2.33 Bn |
| Mar 29, 2015 | 2.33 Bn |
| Dec 28, 2014 | 3.11 Bn |
| Dec 28, 2014 | 3.11 Bn |
| Sep 28, 2014 | 3.90 Bn |
| Sep 28, 2014 | 3.90 Bn |
| Jun 29, 2014 | 4.69 Bn |
| Jun 29, 2014 | 4.69 Bn |
| Mar 30, 2014 | 3.29 Bn |
| Mar 30, 2014 | 3.29 Bn |
| Dec 29, 2013 | 2.71 Bn |
| Dec 29, 2013 | 2.71 Bn |
| Sep 29, 2013 | 5.14 Bn |
| Sep 29, 2013 | 5.14 Bn |
| Jun 30, 2013 | 4.28 Bn |
| Jun 30, 2013 | 4.28 Bn |
| Mar 31, 2013 | 1.69 Bn |
| Mar 31, 2013 | 1.69 Bn |
| Dec 30, 2012 | 2.22 Bn |
| Dec 30, 2012 | 2.22 Bn |
| Sep 30, 2012 | 4.30 Bn |
| Sep 30, 2012 | 4.30 Bn |
| Jul 1, 2012 | 3.65 Bn |
| Jul 1, 2012 | 3.65 Bn |
| Apr 1, 2012 | 2.29 Bn |
| Apr 1, 2012 | 2.29 Bn |
| Jan 1, 2012 | 269.00 Mn |
| Jan 1, 2012 | 269.00 Mn |
| Apr 3, 2011 | 1.88 Bn |
| Apr 3, 2011 | 1.88 Bn |
| Oct 3, 2010 | 4.51 Bn |
| Oct 3, 2010 | 4.51 Bn |
| Jul 4, 2010 | 3.34 Bn |
| Jul 4, 2010 | 3.34 Bn |
| Apr 4, 2010 | 3.29 Bn |
| Apr 4, 2010 | 3.29 Bn |
| Jan 3, 2010 | 4.44 Bn |
| Jan 3, 2010 | 4.44 Bn |
| Sep 27, 2009 | 4.58 Bn |
| Sep 27, 2009 | 4.58 Bn |
| Jun 28, 2009 | 2.80 Bn |
| Jun 28, 2009 | 2.80 Bn |
| Mar 29, 2009 | 2.39 Bn |
| Mar 29, 2009 | 2.39 Bn |